Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
1301
A Hierarchical Contact–Electrification Interface Based on Gradient Micro-/Nanostructured Hydrogel for Cardiovascular Disease Monitoring
Published 2025“…Consequently, the gradient micro-/nanostructured hydrogel, fabricated via electric field induction, enables the sensor’s high-sensitivity region to reach 1.1–52.2 kPa, a 5-fold improvement over that of comparable sensors. …”
-
1302
-
1303
-
1304
-
1305
-
1306
-
1307
-
1308
-
1309
-
1310
Overexpression of TNFAIP9 alleviated the renal fibrosis caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
1311
Overexpression of TNFAIP9 remitted the renal inflammation caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
1312
-
1313
-
1314
Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
1315
-
1316
Plasmids and oligos used in this study.
Published 2024“…The combination of the chromosome 4 CNV and <i>KSR1</i> LOH results in a >500-fold decrease in azole susceptibility relative to the progenitor, illustrating a compelling example of rapid, yet step-wise, interplay between CNV and LOH in drug resistance evolution.…”
-
1317
Strains used in this study.
Published 2024“…The combination of the chromosome 4 CNV and <i>KSR1</i> LOH results in a >500-fold decrease in azole susceptibility relative to the progenitor, illustrating a compelling example of rapid, yet step-wise, interplay between CNV and LOH in drug resistance evolution.…”
-
1318
-
1319
-
1320